Cargando…
Administration of a standardized plasma-protein solution (Biseko(®)) in high-risk patients with systemic inflammatory response syndrome: influence on cytokine levels and survival
Autores principales: | Meyer, B, Bojic, A, Locker, GJ, Staudinger, T, Wulkersdorfer, B, Müllner, M, Spittler, A, Schuster, E, Reith, B, Kaye, A, Frass, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088599/ http://dx.doi.org/10.1186/cc6449 |
Ejemplares similares
-
Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999) -
Outcome and prognostic factors in critically ill immunocompromised patients admitted to the ICU
por: Schellongowski, P, et al.
Publicado: (2004) -
Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin)(®)
por: Schellongowski, P, et al.
Publicado: (2003) -
Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999) -
Short-term effects of combining upright and prone positions in patients with ARDS: a prospective randomized study
por: Robak, Oliver, et al.
Publicado: (2011)